1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

TopiVert

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

London UK

Primary Industry

Biotechnology

About

TopiVert, is based in London, UK and focused on the discovery of topical kinase inhibitors for inflammatory conditions of the eye and gut.
Current Investors
SV Health Investors, Touchstone Innovations, NeoMed

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.